Login
$IRHO
$10.10 -$0.02 (0.2%) Live

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2026
As of Aug 31, 2026
Q2 FY2026
As of May 31, 2026
Q1 FY2026
As of Feb 28, 2026
Q4 FY2025
As of Nov 30, 2025
ASSETS
Current assets
Cash
Notes receivable
Prepaid expenses
Total current assets
Long-term prepaid insurance
Deferred offering costs
Cash and investments held in Trust Account
TOTAL ASSETS
LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT
Current liabilities
Accounts payable and accrued expenses
Accrued expenses
Accrued expenses – related party
Accrued offering costs
Due to Sponsor
Related Party
Total due to Sponsor
Promissory note – related party
Total Current Liabilities
Deferred legal fees
Deferred underwriting fee
Total Liabilities
Ordinary shares subject to possible redemption, $0.0001 par value; 23,000,000 and no shares at redemption value of approximately $10.25 and $0 per share at August 31, 2026 and November 30, 2025, respectively
Shareholders’ Deficit
Ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 6,320,000 and 5,750,000 shares issued and outstanding (excluding 23,000,000 and no shares subject to possible redemption) at August 31, 2026 and November 30, 2025, respectively
Additional paid-in capital
Accumulated deficit
Total Shareholders’ Deficit
TOTAL LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support